Fate Therapeutics (FATE) Net Margin (2012 - 2026)
Fate Therapeutics' Net Margin came in at -1450.53% for Q2 2026, up 336.05 percentage points from -1786.58% a year earlier and up 952.32 percentage points from the prior quarter.
Powered by 
Analysis
Fate Therapeutics (FATE) Net Margin (2012 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Fate Therapeutics reported Net Margin of -1941.72%, up 83.33 percentage points year-over-year; for FY2025, it came in at -2051.08%, down 684.62 percentage points from FY2024.
- Net Margin carries a five-year change of -1499.49 percentage points (FY2020 to FY2025).
- Going back by year, Net Margin was -1366.46% in FY2024 (-1113.16 pp), -253.30% in FY2023 (+39.25 pp), -292.55% in FY2022 (+87.34 pp) and -379.89% in FY2021 (+171.70 pp).
- The Q2 2026 figure represents the highest quarterly Net Margin since Q2 2024.
- Year-over-year, Net Margin increased in four of the last eight quarters, with an average year-over-year change of -6.66 percentage points.
- The fastest year-over-year change in Net Margin over five years came in Q2 2024 (a gain of 5086.90 percentage points), and the weakest in Q2 2023 (a drop of 5244.05 percentage points).
- Business Quant data shows FATE's Net Margin at -2402.85% (Q1 2026), -2364.79% (Q4 2025) and -1852.38% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 21.86% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 21.27% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -8.04% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 22.61% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 18.81% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 23.62% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -134.51% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -1.65% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 32.99% |
| 10 | Fate Therapeutics | 277.73 Mn | 277.73 Mn | - | -1,450.53% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -1,450.53% |
| Mar 31, 2026 | -2,402.85% |
| Dec 31, 2025 | -2,364.79% |
| Sep 30, 2025 | -1,852.38% |
| Jun 30, 2025 | -1,786.58% |
| Mar 31, 2025 | -2,309.45% |
| Dec 31, 2024 | -2,803.92% |
| Sep 30, 2024 | -1,551.01% |
| Jun 30, 2024 | -567.44% |
| Mar 31, 2024 | -2,493.71% |
| Dec 31, 2023 | -2,632.58% |
| Sep 30, 2023 | -2,323.56% |
| Jun 30, 2023 | -5,654.34% |
| Mar 31, 2023 | -32.01% |
| Dec 31, 2022 | -127.07% |
| Sep 30, 2022 | -557.79% |
| Jun 30, 2022 | -410.29% |
| Mar 31, 2022 | -356.74% |
| Dec 31, 2021 | -402.02% |
| Sep 30, 2021 | -304.45% |
API Access
Fate Therapeutics Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=FATE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "FATE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=FATE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();